[HTML][HTML] A Review of the Important Role of CYP2D6 in Pharmacogenomics

C Taylor, I Crosby, V Yip, P Maguire, M Pirmohamed… - Genes, 2020 - mdpi.com
Cytochrome P450 2D6 (CYP2D6) is a critical pharmacogene involved in the metabolism of~
20% of commonly used drugs across a broad spectrum of medical disciplines including …

PharmVar GeneFocus: CYP2D6

C Nofziger, AJ Turner, K Sangkuhl… - Clinical …, 2020 - Wiley Online Library
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly
polymorphic human CYP2D6 gene locus. CYP2D6 genetic variation impacts the metabolism …

In Silico ADME/Tox Profiling of Natural Products: A Focus on BIOFACQUIM

NA Durán-Iturbide, BI Díaz-Eufracio… - ACS …, 2020 - ACS Publications
Natural products continue to be major sources of bioactive compounds and drug candidates
not only because of their unique chemical structures but also because of their overall …

[HTML][HTML] Recommendations for clinical CYP2D6 genotyping allele selection: a joint consensus recommendation of the Association for Molecular Pathology, College of …

VM Pratt, LH Cavallari, AL Del Tredici… - The Journal of Molecular …, 2021 - Elsevier
The goals of the Association for Molecular Pathology Clinical Practice Committee's
Pharmacogenomics (PGx) Working Group are to define the key attributes of …

Synthesis, molecular docking, and in silico ADME/Tox profiling studies of new 1-aryl-5-(3-azidopropyl) indol-4-ones: Potential inhibitors of SARS CoV-2 main protease

FX Domínguez-Villa, NA Durán-Iturbide… - Bioorganic …, 2021 - Elsevier
The virus SARS CoV-2, which causes the respiratory infection COVID-19, continues its
spread across the world and to date has caused more than a million deaths. Although …

[HTML][HTML] Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19

AB Koopmans, MH Braakman, DJ Vinkers… - Translational …, 2021 - nature.com
Extensive migration has led to the necessity of knowledge regarding the treatment of
migrants with different ethnical backgrounds. This is especially relevant for pharmacological …

[HTML][HTML] Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

CC Almeida-Brasil, JG Hanly, M Urowitz… - Annals of the …, 2022 - ard.bmj.com
Objectives To evaluate systemic lupus erythematosus (SLE) flares following
hydroxychloroquine (HCQ) reduction or discontinuation versus HCQ maintenance. Methods …

[HTML][HTML] Contribution of genetic polymorphisms in human health

P Chiarella, P Capone, R Sisto - International Journal of Environmental …, 2023 - mdpi.com
Human health is influenced by various factors; these include genetic inheritance, behavioral
lifestyle, socioeconomic and environmental conditions, and public access to care and …

[HTML][HTML] Addressing ancestry and sex bias in pharmacogenomics

M Corpas, MK Siddiqui, O Soremekun… - Annual review of …, 2024 - annualreviews.org
The association of an individual's genetic makeup with their response to drugs is referred to
as pharmacogenomics. By understanding the relationship between genetic variants and …

[HTML][HTML] Codeine therapy and CYP2D6 genotype

L Dean, M Kane - 2021 - europepmc.org
Codeine is used to relieve mild to moderately severe pain, and it belongs to the drug class of
opioid analgesics. Codeine has also been prescribed to prevent coughing, though the …